Key Takeaways

  • Dental practice sale pain points fall into four predictable categories: financial and valuation, deal friction, operational and staffing, and emotional. Each category has known mechanisms and pre-emptive fixes.
  • Weak or undocumented EBITDA valuations can be the most consequential pain point. A CPA-led, diligence-grade analysis before going to market can reduce re-trades and protect seller leverage.
  • Post-LOI re-trades, lease assignment issues, and punitive DSO earnout or non-compete terms are common friction points. Competitive tension and early lease review can reduce these risks.
  • Premature staff disclosure and provider concentration risk can erode goodwill and trigger buyer walk-aways. Controlled confidentiality sequencing and operational cleanup can help protect value through closing.
  • McLerran & Associates helps sellers navigate these pain points with sell-side-only representation, CPA-led valuations, and competitive buyer processes that can support higher close rates and stronger outcomes.

Schedule A Free Discovery Call with McLerran & Associates

Financial And Valuation Pain Points: Where The Number Gets Set

The single most consequential dental practice sale pain point can be a weak valuation. Many practices enter the market with a number set by a buyer, derived from a rule of thumb, or produced by a “free” valuation that functions as a lead-generation tool rather than a defensible analysis. That number becomes the anchor for the entire deal, and it often gets reduced in due diligence.

The mechanism is straightforward. Dental practice financials routinely mix personal expenses, discretionary owner spending, and non-recurring items into the profit-and-loss statement. A rigorous normalization process unpacks every add-back line by line with documentation. Without that process, the reported earnings figure either overstates or understates what a buyer will actually inherit. A buyer’s quality-of-earnings (QoE) team, meaning the accountants a buyer hires to verify the seller’s numbers, will rebuild earnings from source data. If the seller’s add-back schedule cannot be evidenced, the disallowed amounts reduce the EBITDA base. Because the price is calculated by multiplying EBITDA by a multiple, a relatively small restatement can move the enterprise value by a significant amount. One illustrative example from industry analysis shows a $130,000 restatement at an 8x multiple moving the price by more than $1 million.

The cost to the seller can include re-trades, a lower walk-away number, and lost negotiating leverage at precisely the moment, during exclusivity, when the seller has no competing buyers to fall back on.

A CPA-led, diligence-grade EBITDA analysis done before the deal goes to market can reduce this risk. McLerran & Associates builds this analysis up front, remotely accessing practice management software, cross-referencing production and collections data against financials, and unpacking every discretionary and non-recurring expense. This approach helps the dental practice valuation hold under buyer scrutiny and can reduce the likelihood of a re-trade. With roughly 10,000+ practices evaluated and approximately $2 billion in closed transaction volume, McLerran & Associates has the pattern recognition to see which add-backs tend to survive diligence and which ones can undermine credibility across the schedule.

At McLerran & Associates, every engagement is built on an ironclad, CPA-led EBITDA analysis and practice valuation.
At McLerran & Associates, every engagement is built on an ironclad, CPA-led EBITDA analysis and practice valuation.

Sellers should also consult their own CPA and legal advisors on how purchase-price allocation across asset classes such as goodwill, equipment, and non-compete covenants affects after-tax proceeds. Tax consequences can vary materially depending on entity type, state, and deal structure. For a deeper look at where valuation analysis can go wrong, see Dental Practice Valuation Mistakes That Cost Sellers Money.

Deal Friction Pain Points: Re-Trades, Leases, And DSO Terms

Even a well-valued practice can lose significant value between the letter of intent and closing. The dental practice sale process contains several friction points that are predictable and often preventable.

Post-LOI re-trades and unreliable buyers. A letter of intent is typically non-binding on price. Once exclusivity begins, commonly about 60 to 120 days, with 90 days a typical term, the seller cannot solicit competing offers, and the buyer’s QoE team begins a forensic review of the financials. A seller who enters exclusivity with only one buyer and a valuation that cannot withstand scrutiny has no fallback. Any finding then becomes leverage. One industry analysis, citing the SRS Acquiom 2025 M&A Deal Terms Study, suggests a large majority of lower-middle-market transactions face post-LOI purchase price adjustments after quality-of-earnings review, though the figure is not dental-specific and the precise frequency varies by deal type and source.

Competitive tension is the pre-emptive fix. A structured, auction-like bid process among multiple vetted buyers means a finding becomes a conversation the seller can absorb, challenge, or walk away from to the next bidder. McLerran & Associates typically generates around 10 offers per DSO listing over a 45-to-60-day process, which can preserve that leverage through diligence.

The lease and real estate assignment trap. Re-trades are the loudest friction point, but they are not the only one. A lease that cannot be assigned or is near expiration is among the most common deal-critical findings in dental practice diligence. Nearly every commercial lease requires landlord consent before the tenant’s interest can be assigned to a new entity, and a landlord who learns of the sale from the buyer’s attorney may use the moment to renegotiate rent. A short remaining term forces the buyer to underwrite a renegotiation they do not control. Buyers often price that uncertainty as risk against the offer.

Early lease review can reduce this exposure. Sellers can confirm remaining term, renewal options, assignment language, and the landlord’s consent rights well before the deal goes to market. For a full treatment of this issue, see Dental Practice Sale Lease Issues: A Seller’s Playbook.

DSO terms: non-competes, working agreements, earnouts, and equity rollover. DSO deals are rarely all cash. DSO offers typically lead with 60% to 80% of a deal’s value as cash at closing, with the remainder rolled into joint venture or holding company equity, and earnouts, meaning payments contingent on post-closing performance targets, can make up an additional portion.

That structure is where much of the risk sits. Because the seller no longer controls fee schedules, payer contracts, hygiene staffing, or marketing spend, a punitive earnout can tie the remaining payout to inputs the seller cannot influence. Long non-competes and restrictive working agreements compound that exposure.

Non-punitive earnout negotiation can help. Examples include pro-rata provisions so a near-miss on an EBITDA target still pays most of the earnout. Early, informed comparison of deal structures across multiple buyers also matters. McLerran & Associates produces multi-year, multi-structure financial forecasting so sellers can compare real after-tax proceeds across deal structures before signing anything. Sellers should work with their own CPA and attorney to model the tax and legal consequences of each structure before the LOI is executed.

Dental Practice Sale Success Rate: What Controls It covers the broader set of factors that can influence whether a deal closes at the agreed value.

Schedule A Free Discovery Call

Operational And Staffing Pain Points: Protecting Goodwill

A dental practice’s goodwill, meaning the transferable value of its patient relationships, staff continuity, and reputation, is the most fragile asset in the deal. That goodwill can erode before closing if the sale process is not managed carefully.

Premature or uncontrolled disclosure is the primary mechanism. When staff learn about a potential sale from a rumor, a patient comment, or an overheard conversation rather than from a deliberate communication plan, the consequences can be significant. Staff continuity is among the top value drivers in a dental practice acquisition. A hygienist with a long-standing patient relationship or an associate generating a substantial share of collections is difficult to replace on short notice, and their departure in the 90 days after closing can reduce collections materially. Buyers scrutinize provider concentration, meaning the degree to which production depends on the selling dentist or a small number of key staff, as a primary risk factor. Provider risk and clinical continuity were the leading reasons buyers restructured offers or walked away from dental deals in 2026.

Front-desk and systems leaks present a related risk. Scheduling anomalies, unusual after-hours activity, or changes in vendor relationships can signal a pending sale to staff and patients before the seller is ready to communicate. Operational cleanup also matters. Addressing deferred maintenance, staffing gaps, and billing irregularities can be critical because buyers run algorithms against practice management software data and often find issues the seller assumed were invisible.

Controlled confidentiality sequencing is the practical fix. This means a deliberate plan for when and how staff are informed, coordinated with the buyer and the advisor, so the announcement is managed rather than leaked. McLerran & Associates manages disclosure timing as part of the transaction process, acting as a buffer between seller and buyer to help protect staff relationships and goodwill through closing.

A chat at McLerran & Associates: the dental-specific sell-side advisor and advocate for practice owners guides on how, when, and to whom to sell your practice.
A chat at McLerran & Associates: the dental-specific sell-side advisor and advocate for practice owners guides on how, when, and to whom to sell your practice.

Emotional Pain Points: Identity, Burnout, And The Right Fit

The emotional dimension of selling a dental practice carries real financial weight. A dentist who has spent 30 or 40 years building a practice has built an identity alongside it. The prospect of selling can surface identity loss, fear of the unknown, and concern about what happens to patients and staff after the transition.

Burnout is also a legitimate driver. Many sellers are motivated by a mix of financial goals and relief from the administrative weight of running a large organization. That “why” shapes which transition path and which buyer structure actually fits.

The right buyer is not always the highest bidder. A buyer whose strategy, support model, or culture is a poor fit for the practice’s patients and staff can erode the legacy the seller spent a career building. Strong fit protects the seller’s peace of mind and the goodwill that was priced into the deal.

McLerran & Associates is sell-side only, so it never represents the buyer. Its incentives are fully aligned with the selling dentist. The firm focuses on both price and fit, and its first job in any engagement is to understand the seller’s “why” before recommending a path. That alignment can provide a structural answer to many emotional pain points because the seller has an advocate whose interests do not conflict with theirs.

McLerran & Associates team: McLerran is the nation's largest dental-specific sell-side M&A advisory and brokerage firms
McLerran & Associates team: McLerran is the nation's largest dental-specific sell-side M&A advisory and brokerage firms

Pre-Sale Preparation Timeline: Turning Pain Points Into A 24-Month Plan

The four pain-point categories above share one common defense: lead time. The earlier a seller starts, the more of these failure modes can be engineered out before a buyer ever sees the numbers. The sequence below maps those fixes to a practical preparation timeline.

  • 24 Months Out: Begin financial cleanup. Separating personal and discretionary expenses from practice financials is the first step because a CPA cannot normalize earnings until the raw numbers are clean. Once the books are clean, the CPA can identify which add-backs will likely survive diligence. That normalized figure should then support a diligence-grade valuation so the seller understands the real number, rather than a buyer-set anchor, and has time to improve it. McLerran & Associates builds this analysis up front and will update it for free a year later if the seller is not yet ready to move.
  • 12 Months Out: Review the lease. Confirm remaining term, renewal options, and assignment language. Address any entity structure issues with a CPA and attorney so the practice is transaction-ready. Begin educating yourself on the buyer market, including which DSOs are active, what private buyers look like, and how a side-by-side comparison of both paths plays out for your specific practice.
  • 6 Months Out: Develop a confidentiality plan. Identify which staff members need to know and when. Address operational gaps such as staffing vacancies, deferred maintenance, and billing irregularities that buyers will find in diligence. Assemble the documentation a buyer will request, including 3 years of financials, production and collections reports, payer mix data, active patient counts, and staff agreements.

For owners who have not yet decided whether to sell, the McLerran M&A Summit (October 29–30, 2026, Austin) is built for exactly that stage. Attendees receive a complimentary practice valuation (a $2,500 value), 4 CE credits, and access to CPA-led sessions on deal structures, EBITDA, and the DSO and private-equity landscape, with no pressure to commit to anything. For a detailed look at the full preparation sequence, see How To Maximize Dental Practice Sale Price: 24-Month Plan.

Every Pain Point Is Survivable

Every dental practice sale pain point described in this guide can be survivable when the seller gets ahead of it. These pain points do not arise from random bad luck. They tend to follow predictable failure modes with known mechanisms, known costs, and known fixes.

The decisive factor in whether a seller experiences them can be dental-specific, sell-side representation from an advisor whose valuation holds under scrutiny, whose process creates competitive tension, and whose incentives align with the seller’s goals.

McLerran & Associates has guided owners through approximately 2,000 successful practice sales and closed roughly $2 billion in transaction volume. Its transaction rate of approximately 85–90%, compared to an industry norm closer to 35–40%, reflects what can happen when the common failure modes are addressed before the deal goes to market.

Owners who are considering a transition, whether now or in the future, can start with a confidential conversation. Call (512) 900-7989, email info@dentaltransitions.com, or visit the link below to schedule a free, confidential discovery call.

Schedule A Free Discovery Call

Frequently Asked Questions

Is It Hard To Sell A Dental Practice?

Selling a dental practice can be one of the more complex financial transactions a dentist will undertake. The process involves a diligence-grade valuation, a competitive buyer process, lease and entity review, staff confidentiality management, and negotiation of deal structure, all while the seller continues running a clinical practice. Without experienced representation, do-it-yourself close rates can run as low as 15–20%, compared to roughly 80% for a well-run brokered process. Preparation quality, valuation defensibility, and competitive tension can be some of the main factors behind that gap. Dental-specific, sell-side representation from a firm like McLerran & Associates addresses each of those variables directly.

What Are The Main Pain Points Of Selling A Dental Practice?

The main pain points of selling a dental practice usually show up in a few recurring ways. Weak or undocumented EBITDA analysis can be re-traded in diligence, which reduces price and leverage. Deal friction often arises from post-LOI re-trades in single-buyer negotiations, lease assignment complications, and punitive DSO earnout and non-compete terms. Operational and staffing issues can include premature disclosure that panics staff, provider concentration risk, and operational gaps that buyers uncover in diligence. Emotional factors such as identity loss, burnout, and concern about legacy, patients, and staff also influence decisions. Each of these areas has a mechanism, a cost to the seller, and practical steps that can reduce the risk.

How Do I Avoid Re-Trades After The LOI?

Re-trades, meaning price reductions after the letter of intent is signed, are most commonly driven by two factors: a valuation that cannot withstand buyer scrutiny and a single-buyer negotiation that removes competitive tension. A diligence-grade EBITDA analysis done before the deal goes to market, with every add-back documented and defensible, can address the first factor. A structured, competitive bid process that keeps multiple qualified buyers at the table through diligence can address the second. McLerran & Associates builds CPA-led valuations up front and runs an auction-like process so the seller retains leverage even after exclusivity begins. When a buyer’s quality-of-earnings team finds nothing new, they have less basis to reopen the number.

Are DSO Deals All Cash, Or Do They Include Equity And Earnouts?

DSO deals are almost always a mix of cash, equity, and earnouts. As noted above, cash at close is typically the majority of total consideration, with the remainder structured as rollover equity, meaning an ownership stake in the DSO or its affiliated entity, and earnouts tied to post-closing performance. Rollover equity can be held at the joint-venture level, which often provides distributions but a lower ceiling, or at the holding-company level, which may not provide distributions but can offer higher potential upside. As much as 40% of a DSO deal can be paid in equity rather than cash, so the seller effectively becomes an investor in the DSO and should evaluate the buyer’s financial health, management team, and private equity backing carefully.

Earnout terms vary widely. Non-punitive structures can include pro-rata provisions that pay most of the earnout even on a near-miss, while punitive structures can shift significant business risk to the seller after closing. McLerran & Associates produces multi-year, multi-structure financial forecasting so sellers can compare real after-tax proceeds across deal structures before signing. Sellers should work with their own CPA and attorney to model the tax consequences of each component.

How Do I Keep Staff Calm During A Sale?

The most effective approach is controlled confidentiality sequencing, meaning a deliberate plan for when and how staff are informed, developed in advance and coordinated with the advisor and buyer. Premature or uncontrolled disclosure through rumors, scheduling anomalies, or overheard conversations can cause key staff to leave before closing, which erodes goodwill and can trigger a buyer re-trade or walkaway. The communication plan should specify who is told first, what they are told, and when the broader team is informed. Retention considerations, such as stay-on arrangements for key staff, can also be built into the deal structure. McLerran & Associates manages disclosure timing as part of the transaction process, acting as a buffer between seller and buyer to help protect staff relationships through closing.

Is Now A Good Time To Sell?

Demand for premier, well-prepared dental practices remains strong. Industry data indicate that dental practice valuations have held in a range of roughly 5x to 9x+ EBITDA over the prior 2 years, and more than 78% of buyers surveyed in 2026 indicated they expected to complete a recapitalization within the next 12 to 36 months, which creates a near-term window for owners of financially healthy practices. The market is not uniform, however. Offer spreads have widened, buyer scrutiny of financials and operations has intensified, and geography and payer mix now affect valuations more than they did a few years ago.

The right timing depends on the specific practice, its financials, and the seller’s goals. McLerran & Associates will provide a candid assessment of how a specific practice is positioned. If the timing does not look favorable, the firm will update the valuation for free a year later rather than push a seller into a deal that does not serve them.

What to Read Next

Get In Touch